Ambri dumps IP value and reels in $15m
17 July, 2003 by Jeremy TorrSydney bio-nano company Ambri has raised AUD$15.5 million through a placement of ordinary shares to a mix of existing and new institutional investors, and simultaneously announced it will write off $20.7 million worth of IP value from its accounts.
New WEHI facility opens door to drug design
17 July, 2003 by Melissa TrudingerThe head of the structural biology division at Melbourne's Walter and Eliza Hall Institute has tipped "one to two new drugs" will be developed at the facility in the next five years.
ToxiTech investment the latest in Qld biotech funding spree
17 July, 2003 by Pete YoungThe funding floodgates suddenly appear to have swung open for young and not-so-young biotechs -- at least in Queensland.
Leading Australian scientist attacks GM moratoria
17 July, 2003 by Graeme O'NeillWith a nationwide freeze in place on commercial production of genetically modified canola, Australia's leading plant geneticist delivered a warning to GM-shy state governments yesterday: use it, or lose markets.
Agbiotech forum looks back to the future
16 July, 2003 by Jeremy TorrAgricultural scientists and biotech researchers should not concentrate on new biotechnology solutions at the expense of traditional methods -- the latter still have plenty of promise, a recent Sydney forum has been told.
Cardia subsid signs global moth control deal
16 July, 2003 by Melissa TrudingerCardia subsidiary Bioglobal has signed a marketing and distribution agreement with Cotton Growers Services, a joint venture company owned by Bayer CropScience and Syngenta, for a product to control the Heliothis moth.
AGT files more diabetes, obesity patents
16 July, 2003 by Melissa TrudingerAGT Biosciences says it has filed another three patent applications for genes involved in diabetes and obesity.
Prima boosted by Cancer Vac trial results
15 July, 2003 by Melissa TrudingerPrima BioMed subsidiary Cancer Vac has announced positive results from the Phase Ib clinical trial of its cancer vaccine immunotherapy.
Capital raising buys time for Alchemia
15 July, 2003 by Pete YoungBrisbane firm Alchemia has capped a lengthy hunt for additional investment by securing $2.75 million in fresh funding, according to CEO Tracie Ramsdale.
Peptech patent approved
15 July, 2003 by Jeremy TorrPeptech's application for a patent on antibodies or antibody fragments that bind to a specific tumour necrosis factor (TNF) has been given the green light by US patent authorities.
Agenix locates DVT clot in clinical trials
11 July, 2003 by Jeremy TorrThrombosis diagnostic specialist Agenix has successfully detected a deep vein thrombosis (DVT) clot in the leg of a patient during Phase Ib clinical trials.
ABI joins call for Aussie roo genome
10 July, 2003 by Iain ScottSequencing instrument company Applied Biosystems has joined the call for a marsupial genome project to be conducted in Australia rather than the US.
Scientists 'terrified' by HK bird flu: Doherty
10 July, 2003 by Graeme O'NeillThe risk of a SARS pandemic sweeping the world appears to be over, to the great relief of international health authorities who have been awaiting another pandemic of the magnitude of the Spanish 'flu pandemic of 1918-19, which killed an estimated 20 million people on six continents.
Botstein awarded Gruber prize
10 July, 2003 by Iain ScottDr David Botstein, of the Lewis-Sigler Institute for Integrative Genomics at Princeton University, was yesterday awarded the prestigious 2003 Peter Gruber Genetics prize.
Research exposes fire ant's Achilles heel
09 July, 2003 by Graeme O'NeillAcross large areas of the southern United States, the most social primate on Planet Earth has come into painful conflict with one of the world's most unlovable social insects - the South American fire ant, Solenopsis victor.
